Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment

Study acronym: AMBIZYGO
StatusCompleted
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Publications: details revised at 1 of 1 entry
    • Collaborators expanded, about 5 words
    v8
  2. Study description shortened, about 39 words
    • Study title shortened, about 1 word
    v7
  3. Trial status: Active, Not Recruiting to Completed
    • Study completion date changed from estimate of Dec 2012 to Mar 2013
    v6
  4. Study completion date: Jun 2012 to Dec 2012v5
  5. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Mar 2011 to Jun 2011
    • Study completion date: Sep 2011 to Jun 2012
    • Site details revised at 2 of 2 sites
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date changed from estimate of Jul 2010 to Mar 2011
    • Study completion date: Sep 2010 to Sep 2011
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 6 more changesShow less
    • Enrollment target: 14 to 40
    • Study sites: 1 to 2
    • Primary completion date: Jul 2010
    • Study completion date: May 2009 to Sep 2010
    • Start date: May 2007 to Jun 2007
    • Study arms: 0 to 1
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluation after 4 weeks of treatment or at end of treatment if it occurs before. Efficacy will be defined as objective responses; complete and partial response.
Trial Details
NCT Number NCT00467883
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: URC-CIC Paris Descartes Necker Cochin
Conditions
(from sponsor)		 Zygomycosis
Related terms Zygomycosis
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov